Langxia Liu

MOE Key Laboratory Of Tumor Molecular Biology And State Key Laboratory Of Bioactive Molecules And Druggability Assessment
Guangzhou, 510632, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Corrigendum to "TRIAL-based combination therapies in cancers" [Int. Immunopharmacol. 138 (2024) 112570].

Corrigendum to "TRIAL-based combination therapies in cancers" [Int. Immunopharmacol. 138 (2024) 112570].

Journal: International immunopharmacology

Published: May 09, 2026

Correction: Artesunate induces ferroptosis in diffuse large B-cell lymphoma cells by targeting PRDX1 and PRDX2.

Correction: Artesunate induces ferroptosis in diffuse large B-cell lymphoma cells by targeting PRDX1 and PRDX2.

Journal: Cell death & disease

Published: April 29, 2026

Artesunate induces ferroptosis in diffuse large B-cell lymphoma cells by targeting PRDX1 and PRDX2.

Artesunate induces ferroptosis in diffuse large B-cell lymphoma cells by targeting PRDX1 and PRDX2.

Journal: Cell death & disease

Published: January 21, 2025

FAM210B activates STAT1/IRF9/IFIT3 axis by upregulating IFN-α/β expression to impede the progression of lung adenocarcinoma.

FAM210B activates STAT1/IRF9/IFIT3 axis by upregulating IFN-α/β expression to impede the progression of lung adenocarcinoma.

Journal: Cell death & disease

Published: May 26, 2024

TRIAL-based combination therapies in cancers.

TRIAL-based combination therapies in cancers.

Journal: International immunopharmacology

Published: May 20, 2024

Artesunate induces ferroptosis by regulating MT1G and has an additive effect with doxorubicin in diffuse large B-cell lymphoma cells.

Artesunate induces ferroptosis by regulating MT1G and has an additive effect with doxorubicin in diffuse large B-cell lymphoma cells.

Journal: Heliyon

Published: October 31, 2023

Ferroptosis in cancer (Review).

Ferroptosis in cancer (Review).

Journal: Oncology letters

Published: October 24, 2023

Exosomal PPARγ derived from macrophages suppresses LPS-induced peritonitis by negative regulation of CD14/TLR4 axis.

Exosomal PPARγ derived from macrophages suppresses LPS-induced peritonitis by negative regulation of CD14/TLR4 axis.

Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]

Published: March 06, 2023

ZSWIM1 Promotes the Proliferation and Metastasis of Lung Adenocarcinoma Cells through the STK38/MEKK2/ERK1/2 Axis.

ZSWIM1 Promotes the Proliferation and Metastasis of Lung Adenocarcinoma Cells through the STK38/MEKK2/ERK1/2 Axis.

Journal: Journal of proteome research

Published: December 13, 2022

Polyphyllin D punctures hypertrophic lysosomes to reverse drug resistance of hepatocellular carcinoma by targeting acid sphingomyelinase.

Polyphyllin D punctures hypertrophic lysosomes to reverse drug resistance of hepatocellular carcinoma by targeting acid sphingomyelinase.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: December 01, 2022

GSK3β/ITCH/c-FLIP Axis Counteracts TRAIL-induced Apoptosis in Human Lung Adenocarcinoma Cells.

GSK3β/ITCH/c-FLIP Axis Counteracts TRAIL-induced Apoptosis in Human Lung Adenocarcinoma Cells.

Journal: Protein and peptide letters

Published: September 06, 2022

DDX17 promotes the growth and metastasis of lung adenocarcinoma.

DDX17 promotes the growth and metastasis of lung adenocarcinoma.

Journal: Cell death discovery

Published: July 01, 2022

Showing 1-12 of 30

Last Updated: 09/26/2026